APLTApplied Therapeutics Inc.

Nasdaq www.appliedtherapeutics.com


$ 4.62 $ -0.09 (-1.91 %)    

Thursday, 09-May-2024 15:59:54 EDT
QQQ $ 441.40 $ 1.34 (0.3 %)
DIA $ 394.43 $ 3.95 (1.01 %)
SPY $ 520.56 $ 3.37 (0.65 %)
TLT $ 90.69 $ 0.50 (0.55 %)
GLD $ 216.93 $ 3.35 (1.57 %)
$ 4.71
$ 4.61
$ 0.00 x 0
$ 0.00 x 0
$ 4.58 - $ 4.74
$ 1.18 - $ 9.39
344,476
na
590.25M
$ 1.26
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-06-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-23-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-12-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-10-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-11-2021 03-31-2021 10-Q
14 03-18-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-11-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-13-2020 12-31-2019 10-K
19 11-13-2019 09-30-2019 10-Q
20 08-12-2019 06-30-2019 10-Q
21 06-21-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rbc-capital-reiterates-outperform-on-applied-therapeutics-maintains-12-price-target

RBC Capital analyst Brian Abrahams reiterates Applied Therapeutics (NASDAQ:APLT) with a Outperform and maintains $12 price t...

 fda-presses-delay-button-for-applied-therapeutics-first-potential-marketed-drug-for-rare-disease

FDA extends the review period for Applied Therapeutics' NDA for govorestat, targeting Classic Galactosemia treatment. The n...

 why-doma-holdings-shares-are-trading-higher-by-around-34-here-are-20-stocks-moving-premarket

Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transa...

 oxford-industries-posts-weak-results-joins-applied-therapeutics-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

U.S. stock futures were higher this morning, with the Dow futures gaining by over 100 points on Monday.

 applied-therapeutics-says-fda-has-extended-review-period-for-nda-for-govorestat-at-007-for-treatment-of-classic-galactosemia-by-three-months-pdufa-target-action-date-november-28-2024

The FDA notified Applied Therapeutics that it required additional time to review supplemental analyses of previously submitted ...

 rbc-capital-initiates-coverage-on-applied-therapeutics-with-outperform-rating-announces-price-target-of-12

RBC Capital analyst Brian Abrahams initiates coverage on Applied Therapeutics (NASDAQ:APLT) with a Outperform rating and ann...

 applied-therapeutics-files-prospectus-for-disposition-from-time-to-time-by-selling-stockholders-of-up-to-143m-shares-of-common-stock

-SEC Filing

 ubs-maintains-buy-on-applied-therapeutics-raises-price-target-to-13

UBS analyst Esther Rajavelu maintains Applied Therapeutics (NASDAQ:APLT) with a Buy and raises the price target from $12 to ...

 eqt-genie-energy-and-other-big-stocks-moving-lower-on-monday

U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.

 ubs-maintains-buy-on-applied-therapeutics-raises-price-target-to-12

UBS analyst Esther Rajavelu maintains Applied Therapeutics (NASDAQ:APLT) with a Buy and raises the price target from $4 to $12.

 applied-therapeutics-fy-eps-142-beats-144-estimate-sales-999m-miss-1067m-estimate

Applied Therapeutics (NASDAQ:APLT) reported quarterly losses of $(1.42) per share which beat the analyst consensus estimate of ...

 why-bumble-shares-are-trading-lower-by-12-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION